Our results may be helpful in this context since they suggest that ficolin-2 insufficiency has the potential to differentiate between preterms with and without RDS as well as those with mild or more severe disease, at least in the subgroup born at GA<33 (Figure 3). This evidence concerns the gene FCN2 and newborn respiratory distress syndrome.